Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
We also exited American Vanguard (AVD), a turnaround investment we initiated last year following the arrival of a new CEO. Management has made...
— Nathan Fredrick, CFA
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on American Vanguard Corporation
No other institutional pitches found for this ticker yet.
More institutional theses from Riverwater Micro Opportunities Strategy
908 Devices ($MASS), which carries a 1.46% portfolio weight, manufactures point-of-need chemical analysis instruments utilizing handheld mass spectrometry, infrared, and Raman spectroscopy for first responders, hazmat teams, and defense agencies. The manager holds...
Red Violet ($RDVT), which accounts for 4.18% of the fund's portfolio, operates proprietary big-data and identity intelligence platforms (IDI and FOREWARN) that provide real-time background verification, risk mitigation, and identity analytics. The manager holds...
Uranium Royalty ($UROY), representing 2.72% of strategy assets, is a pure-play natural resource royalty company focused on the global nuclear fuel cycle. The manager maintains...